Notice of 2026 Annual Meeting of Stockholders and Proxy Statement
Go to Home
Open index
Open pages thumbnails
Search
Index
Front Cover
Inside Front Cover
Table of Contents
Message from Our Chair of the Board and Our Lead Independent Director
Notice of Annual Meeting of Stockholders
Proxy Statement Highlights
Corporate Governance and Related Matters
Item 1: Election of Directors
Audit Committee Matters
Item 2: Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026
Executive Compensation and Related Matters
Item 3: Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company’s Executive Compensation
Letter from the Management Planning and Development Committee
Compensation Committee Report
Compensation Discussion and Analysis
Compensation of Named Executive Officers
CEO Pay Ratio
Pay Versus Performance
Management Proposal
Item 4: Proposal to Approve the Company’s 2026 Incentive Compensation Plan
Stockholder Proposal
Item 5: Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent
Ownership of and Trading in Our Stock
Other Information
Annex A – Reconciliation of Certain Amounts to the Most Directly Comparable GAAP Measure
Annex B – 2026 Incentive Compensation Plan of CVS Health Corporation
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
Search
Go to Home
Open index
Open page thumbnails
Search
Index
Front Cover
Inside Front Cover
Table of Contents
Message from Our Chair of the Board and Our Lead Independent Director
Notice of Annual Meeting of Stockholders
Proxy Statement Highlights
Corporate Governance and Related Matters
Item 1: Election of Directors
Audit Committee Matters
Item 2: Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026
Executive Compensation and Related Matters
Item 3: Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company’s Executive Compensation
Letter from the Management Planning and Development Committee
Compensation Committee Report
Compensation Discussion and Analysis
Compensation of Named Executive Officers
CEO Pay Ratio
Pay Versus Performance
Management Proposal
Item 4: Proposal to Approve the Company’s 2026 Incentive Compensation Plan
Stockholder Proposal
Item 5: Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent
Ownership of and Trading in Our Stock
Other Information
Annex A – Reconciliation of Certain Amounts to the Most Directly Comparable GAAP Measure
Annex B – 2026 Incentive Compensation Plan of CVS Health Corporation
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
Search
